Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Preformed Line Products (PLPC) Change in Receivables (2016 - 2021)

Preformed Line Products (PLPC) has disclosed Change in Receivables for 5 consecutive years, with -$3.0 million as the latest value for Q4 2014.

  • On a quarterly basis, Change in Receivables rose 48.69% to -$3.0 million in Q4 2014 year-over-year; TTM through Dec 2014 was $2.4 million, a 76.3% decrease, with the full-year FY2025 number at -$7.0 million, down 180.24% from a year prior.
  • Change in Receivables was -$3.0 million for Q4 2014 at Preformed Line Products, down from -$271000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $11.5 million in Q2 2011 to a low of -$13.5 million in Q4 2012.
  • A 5-year average of $1.4 million and a median of $2.3 million in 2012 define the central range for Change in Receivables.
  • Biggest YoY gain for Change in Receivables was 292.44% in 2012; the steepest drop was 3608.31% in 2012.
  • Preformed Line Products' Change in Receivables stood at -$7.3 million in 2010, then skyrocketed by 105.25% to $385000.0 in 2011, then crashed by 3608.31% to -$13.5 million in 2012, then soared by 57.01% to -$5.8 million in 2013, then soared by 48.69% to -$3.0 million in 2014.
  • Per Business Quant, the three most recent readings for PLPC's Change in Receivables are -$3.0 million (Q4 2014), -$271000.0 (Q3 2014), and $867000.0 (Q2 2014).